现存分类群
管理(神学)
人类健康
抗真菌
杠杆(统计)
业务
抗性(生态学)
粮食安全
生物
风险分析(工程)
生物技术
医学
环境卫生
生态学
农业
政治学
微生物学
计算机科学
机器学习
政治
法学
进化生物学
作者
Matthew C. Fisher,Nichola J. Hawkins,Dominique Sanglard,Sarah J. Gurr
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2018-05-17
卷期号:360 (6390): 739-742
被引量:1464
标识
DOI:10.1126/science.aap7999
摘要
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonly used antifungal agents is unprecedented. The azoles, for example, are used not only for human and animal health care and crop protection but also in antifouling coatings and timber preservation. The ubiquity and multiple uses of azoles have hastened the independent evolution of resistance in many environments. One consequence is an increasing risk in human health care from naturally occurring opportunistic fungal pathogens that have acquired resistance to this broad class of chemicals. To avoid a global collapse in our ability to control fungal infections and to avoid critical failures in medicine and food security, we must improve our stewardship of extant chemicals, promote new antifungal discovery, and leverage emerging technologies for alternative solutions.
科研通智能强力驱动
Strongly Powered by AbleSci AI